neurological diseases	NDs
cell membrane-coated nanoparticles	CMCNPs
nanoparticles	NPs
blood–brain barrier	BBB
central nervous system	CNS
ischemic stroke	IS
traumatic brain injury	TBI
multiple sclerosis	MS
glioblastoma multiforme	GBM
Parkinson’s disease	PD
Alzheimer’s disease	AD
brain endothelial cells	BECs
red blood cells	RBCs
white blood cells	WBCs
red cell membrane-coated nanoparticles	RCMCNPs
N-methyl-D-aspartate receptor	NMDAR
reticuloendothelial system	RES
signal regulatory proteinα	SIRPα
reactive oxygen species	ROS
stroke homing peptide	SHP
white cell membrane-coated nanoparticles	WCMCNPs
monocytes/macrophages	MMs
fat extract	FE
catalase	CAT
resolvin D2	RvD2
ischemia/reperfusion	I/R
genistein	GS
curcumin	CUR
indinavir	IDV
rapamycin	RAPA
platelet cell membrane-coated nanoparticles	PCMCNPs
cancer cell membrane-coated nanoparticles	CCMCNPs
doxorubicin	DOX
hydroxychloroquine	HDX
10-hydroxycamptothecin	HCPT
paclitaxel	PTX
stem cell membrane-coated nanoparticles	SCMCNPs
neural stem cells	NSCs
oligodendrocyte progenitor cells	OPCs
neural cell membrane-coated nanoparticles	NCMCNPs
vascular endothelial cells	VECs
cerebral malaria	CM
hybrid cell membrane-coated nanoparticles	HCMCNPs
primary mouse thoracic aorta endothelial cell	PMTAEC
blood-brain tumor barrier	BBTB
immune tumor microenvironment	iTME
β-amyloid protein	Aβ
rabies virus glycoprotein	RVG29
triphenylphosphine cation	TPP
infected RBCs	iRBCs
dihydroartemisinin	DHA